Hot topics from DIA 2026
Hot Topics in Life Sciences Translation Discussed at DIA 2026
Conversations at DIA 2026 reflected growing interest in AI-assisted translation, clinical trial content quality, regulatory readiness, multilingual patient communication, and scalable workflows for sponsors, CROs, and life sciences organizations.
AI Validation
AI Translation Validation for Regulated Content
AI-assisted translation workflows for life sciences require validation-minded quality checks, risk controls, and human oversight for regulated materials.
Clinical Trials
Clinical Trial Translation for Global Study Teams
Global studies depend on accurate translation for protocols, site documents, recruitment materials, patient instructions, and other trial communications.
Informed Consent
Informed Consent and Patient-Facing Translation
Informed consent forms, study participation materials, and multilingual patient communications remain central to trial access and comprehension.
Regulatory
Regulatory Translation and Submission Readiness
Sponsors and regulatory teams need multilingual workflows that support submission-ready content, documentation consistency, and controlled review processes.
Terminology
Terminology Governance Across Global Programs
Terminology management, harmonization, and translation memory governance help improve consistency across long-running life sciences programs.
CRO Workflows
CRO and Sponsor Translation Workflow Optimization
CROs and sponsors continue to look for ways to reduce workflow friction, improve turnaround times, and strengthen multilingual coordination across studies.
Medical Device
Medical Device, IFU, Labeling, and Safety Content Translation
DIA conversations also reflected growing need for translation support across medical device documentation, IFUs, labeling, and safety-related content.
Cost Efficiency
Cost Efficiency Through AI-Assisted and Human-Reviewed Workflows
Organizations are increasingly focused on quality-controlled translation models that combine automation efficiencies with expert human review.